{"nct_id":"NCT00680901","title":"LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib","status":"COMPLETED","status_verified_date":"2025-07","start_date":"2008-06-04","start_date_type":"ACTUAL","primary_completion_date":"2012-09-24","primary_completion_date_type":"ACTUAL","completion_date":"2024-10-03","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}